Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirukumab in Active Lupus Nephritis
NCT01273389Phase 2Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Aug 2011
- Primary completion
- Sep 2013
- Modality
- Monoclonal Antibodies
- Countries
- 6
01
Overview
A Phase 2 trial of sirukumab in lupus nephritis (LN), sponsored by Janssen Pharmaceutical. Started Aug 2011; status: completed.
02
Drugs
sirukumab
03
Conditions
lupus nephritis (LN)
Beyond the preview
Go deeper on NCT01273389.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01273389.